Vaborbactam_COA_24628_MedChemExpress

格式：pdf
大小：91.72 KB
文档页数：1

QIAGEN Endotoxin Removal Solution说明书

Endotoxin Removal Solution Catalog Number E4274Product DescriptionEndotoxins are lipopolysaccharides (LPS), a major component of the Gram-negative bacterial cell wall, and are commonly found as contaminants in plasmid DNA preparations from E. coli. Endotoxins are large, negatively charged molecules that co-purify with DNA on ion exchange and size exclusion columns and in CsCl banding. Endotoxins are extremely potent stimulators of the mammalian immune system and are toxic to primary cells and to animals. The endotoxin toxicity is an obstacle to in vitro and in vivo transfection experiments.Non-ionic detergents, traditionally used for separation of integral membrane proteins,1 can be utilized for removal of endotoxins from DNA solutions by phase separation.2The solubility behavior of a detergent in a dilute, aqueous solution at physiological salt and pH conditions is strongly dependent upon the temperature of the solution. At low temperatures, the detergent forms a clear, micellar solution, but above the cloud point temperature, the micelles form larger, turbid aggregates and ultimately fuse to form a separate phase. The lower phase is detergent-enriched and the detergent-depleted upper phase contains detergent at a concentration slightly above the critical micellar concentration (CMC). Amphiphilic and hydrophobic molecules associated with the micelles of the detergent will aggregate within the detergent-enriched phase, while the soluble, hydrophilic molecules will remain in the detergent-depleted upper phase.Extraction of endotoxin contaminated DNA solutions with the appropriate non-ionic detergent will separate the hydrophilic DNA from the amphiphilic endotoxin. The amphiphilic endotoxin will associate with the lower phase, while the DNA will remain in the upper, detergent-depleted phase.2Reagents and equipment required, but not provided • Water, Molecular Biology Reagent, Catalog Number W4502• E-TOXATE® Water, Catalog Number 2107, or Tris-EDTA (TE) buffer 100×, Catalog NumberT9285• DNA solution (0.5 ml), ~ 1 mg/ml in E-TOXATE®Water or TE buffer• 3 M sodium acetate solution, pH 7.5.• 2-Propanol, Catalog Number I9516, or Ethanol, 190 proof, Catalog Number E7148; 200 proof, CatalogNumber E7023• 70% Ethanol• E-TOXATE®reagents Kits, Catalog Numbers 210A1, 210B1 or 210C1• Ice bucket• Heat block or incubator at 37 °C• Microcentrifuge at room temperature• 1.5 or 2 ml sterile microcentrifuge tubes• Endotoxin-free pipet tips (40-200 µl, 200-1000 µl) Precautions and DisclaimerThis product is for R&D use only, not for drug, household, or other uses. Please consult the Material Safety Data Sheet for information regarding hazards and safe handling practices.StorageStore at room temperature.Note: Removal of endotoxins from DNA preparations can be performed either during the final stage of DNApreparation, or during an earlier stage.Procedures for Endotoxin RemovalDuring the final stage of DNA preparationNote: The procedure described below was performed on plasmid DNA produced in E. coli DH5α cells.• Losses of up to 50% of the DNA are expected. • Use of a DNA concentration above therecommended 1 mg/ml reduces the efficiency ofthe procedure.1. Pipette 500 µl of the DNA solution into a sterilemicrocentrifuge tube.2. Add 50 µl of the 3 M sodium acetate solution to theDNA sample.3. Incubate on ice for 5 minutes.4. Add 100 µl of cold Endotoxin Removal Solution.5. Mix thoroughly and incubate on ice for 10 minutes.The solution should be light blue and clear.6. Incubate the tube at 37 °C for 20 to 30 minutes oruntil the phases separate.7. Spin for 5 minutes at 3000 x g in themicrocentrifuge. The upper phase is colorless and clear, while the lower phase is blue.8. Carefully transfer the upper phase containing theDNA to a clean microcentrifuge tube.9. Repeat steps 4 through 8 twice.10. Add 0.6× volume of 2-propanol. Mix by inversion atroom temperature and centrifuge at 15,000 x g for30 minutes at 4 °C. Alternatively, add2.5× volumes of ethanol. Incubate overnight at –20°C or 20 minutes at –70 °C and centrifuge at15,000 x g for 30 minutes at 4 °C.11. Carefully remove the supernatant12. Wash the DNA pellet twice with cold 70% ethanol.Remove the supernatant.13. Air-dry the pellet.14. Suspend the DNA in 100 µl of endotoxin free wateror TE buffer.15. Determine DNA concentration and endotoxin levelsusing endotoxin assay reagents and compare tothe starting material. During an earlier stage of DNA preparationThis procedure is based on the alkaline lysis of E. coli DH5α cells.3 The endotoxins are removed immediately after alkaline cell lysis, neutralization, and a clarification step. The resulting high salt solution is suitable for the endotoxin removal step. It is performed under “endotoxin free” conditions. The plasticware used is either sterile and disposable, or NaOH-treated. The buffers are prepared with endotoxin free water.1. Add the Endotoxin Removal Solution (0.2× volume)to the cold, crude DNA solution.2. Incubate on ice and mix occasionally by inversionto obtain a homogenous, clear blue solution3. Incubate at 37 °C for 20 to 30 minutes until thephase separation is obvious.4. Spin for 5 minutes at low speed (3000 x g) at roomtemperature.5. Transfer the upper aqueous phase to an endotoxinfree container.6. Proceed with the DNA purification by any method.Use endotoxin-free buffers and containers. References1. Bordier, C., J. Biol. Chem., 256, 1604-1607, (1981).2. Cotten, M. et al., Gene Therapy, 1, 239-246,(1994).3. Sambrook et al., Molecular Cloning, a LaboratoryManual, 2nd Ed. p. 1.38RK,PHC 09/05-1Sigma brand products are sold through Sigma-Aldrich, Inc.Sigma-Aldrich, Inc. warrants that its products conform to the information contained in this and other Sigma-Aldrich publications. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Please see reverse side ofthe invoice or packing slip.。

新型抗阿尔茨海默病药物甘露寡糖二酸

新型抗阿尔茨海默病药物甘露寡糖二酸一、本文概述Overview of this article随着全球人口老龄化趋势的加剧，阿尔茨海默病（Alzheimer's Disease，AD）作为一种慢性神经退行性疾病，已经成为影响老年人生活质量的主要健康问题之一。

其临床表现主要为记忆障碍、失语、失用、失认、视空间技能损害、执行功能障碍以及人格和行为改变等，严重影响了患者的日常生活和社会功能。

目前，尽管已经有一些药物被批准用于治疗阿尔茨海默病，但这些药物在缓解症状、延缓疾病进程方面仍然存在一定的局限性。

因此，研发新型、有效的抗阿尔茨海默病药物成为了当前医学研究的热点和难点。

With the intensification of the global aging trend, Alzheimer's Disease (AD), as a chronic neurodegenerative disease, has become one of the main health problems affecting the quality of life of the elderly. Its clinical manifestations mainly include memory impairment, aphasia, loss of use, loss of recognition, impairment of visual and spatial skills, executive dysfunction, and personality and behavioral changes,which seriously affect the patient's daily life and social function. At present, although some drugs have been approved for the treatment of Alzheimer's disease, these drugs still have certain limitations in alleviating symptoms and delaying disease progression. Therefore, the development of new and effective anti Alzheimer's disease drugs has become a hot and difficult topic in current medical research.近年来，甘露寡糖二酸（Mannosylglycerate，MG）作为一种具有独特生物活性的天然产物，其在抗阿尔茨海默病方面的潜在作用逐渐受到了关注。

缬沙坦

海关编码： WGK Germany：3 危险类别码：R36/37/38 安全说明：S26; S37/39 危险品标志：Xi
2'-氰基联苯-4-醛(I)和L-缬氨酸甲酯进行还原胺化,得到的化合物(Ⅱ)再用戊酰氯进行酰化,层析后得到化合物(II)。然后和Bu3SnN3进行反应,引入四唑,再水解即得产物。
药物说明
01
药理作用
02
药代动力学
03
适应症
04
禁忌症
06
不良反应
05
用法用量
药物的相互作用
注意事项
制剂
缬沙坦属于非肽类、口服有效的血管紧张素Ⅱ（AT）受体拮抗剂。它对Ⅰ型受体（AT1）有高度选择性，可竞争性地拮抗而无任何激动作用。它还可抑制AT1受体所介导的肾上腺球细胞释放醛固醇，但对钾所致的释放，缬沙坦没有抑制作用，这也说明缬沙坦对AT1受体的选择性作用。经各种类型的高血压动物模型的体内试验均表明缬沙坦具有良好的降压作用，对心收缩功能及心率无明显影响。对血压正常的动物则不产生降压作用。口服后吸收迅速，生物利用度为23%。与血浆蛋白结合率为94%～97%。约有70%自粪排出，30%自肾排泄，均呈原形。 t1/2β约为9小时。与食物同时服用并不影响其疗效。高血压病患者一次服用后2小时血压开始下降，4～6小时后达最大降压效应。降压作用可持续24小时。连续用药后2～4周血压下降达最大效应。可与氢氯噻嗪合用，降压作用可以增强。
本品为白色结晶或白色、类白色粉末；有吸湿性。本品在乙醇中极易溶解，在甲醇中易溶，在乙酸乙酯中略溶，在水中几乎不溶。比旋度取本品，精密称定，加甲醇溶解并定量稀释成每1ml中约含10mg的溶液，依法测定（2010年版药典二部附录 ⅥE），比旋度为-64.0°至-69.0°。

分子生物学词汇(中英文对照表 )

下载提示

1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。

Valbenazine_COA_22015_MedChemExpress

页数:1
Disulfiram_COA_25264_MedChemExpress

页数:1
Itacitinib_COA_21846_MedChemExpress

页数:1
EC330_COA_24948_MedChemExpress

页数:1
Ponesimod_COA_24876_MedChemExpress

页数:1
Peimisine_COA_25388_MedChemExpress

页数:1
A66_COA_17235_MedChemExpress

页数:1
Tubercidin_COA_20485_MedChemExpress

页数:1
Propidium_Iodide_COA_25757_MedChemExpress

页数:1
VAL-083_23261-20-3_CoA_MedChemExpress

页数:1
Balapiravir_690270-29-2_CoA_MedChemExpress

页数:1
Calcipotriol_COA_25731_MedChemExpress

页数:1

Vaborbactam_COA_24628_MedChemExpress

合集下载

QIAGEN Endotoxin Removal Solution说明书

新型抗阿尔茨海默病药物甘露寡糖二酸

缬沙坦

分子生物学词汇(中英文对照表 )

文档推荐

最新文档